Moderna eyes third quarter for first doses of potential COVID-19 vaccine with Catalent dealReuters • 06/25/20
Covid Report: Moderna Plunges On Suggestion NIH Might Own Its VaccineInvestors Business Daily • 06/25/20
Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine CandidateBusiness Wire • 06/25/20
How The Coronavirus Pandemic Could Give Rise To A New Type Of VaccineInvestors Business Daily • 06/19/20
Early Coronavirus Vaccines Likely To Target Further Complications, Not Infection, Health Experts SayBenzinga • 06/15/20